PCOS Condition Renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS)

A global group of medical experts and patient advocates has announced a new name for polycystic ovary syndrome (PCOS), now to be known as polyendocrine metabolic ovarian syndrome (PMOS). This change, reported in The Lancet, aims to better reflect the condition's endocrine and metabolic aspects, moving beyond a sole focus on ovarian cysts. The renaming is intended to improve clarity, diagnosis, and research efforts.